P20. New software solution for TPS quality control

Introduction In radiation therapy, one of the most time consuming step is due to the Treatment Planning System (TPS) and quality control algorithms for the dose computations. Using Artificial Neural Network (ANN), it is possible to compute the doses inside a phantom resulting from ionizing radiation...

Full description

Saved in:
Bibliographic Details
Published inPhysica medica Vol. 32; pp. 375 - 376
Main Authors Leni, P.E, Gschwind, R, Makovicka, L
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.12.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction In radiation therapy, one of the most time consuming step is due to the Treatment Planning System (TPS) and quality control algorithms for the dose computations. Using Artificial Neural Network (ANN), it is possible to compute the doses inside a phantom resulting from ionizing radiations [1,2]. Material and methods More precisely, once the ANN is trained, it can compute a dose for every voxels of the phantom according to the beam characteristics. The main advantage is the computation time: the time-consuming step is the training of the ANN, that has to be performed only once and offline. The execution time, i.e. the dose associated to a voxel, is very low. We present an evolution of the platform presented in [3] , to take into account various field sizes and shapes, and also consider different orientation of the beam to the phantom. To validate the ANN computations, we compare them with Monte Carlo simulations. Homogeneous phantoms are used to validate interpolations on various densities and depth. Then, realistic phantoms are created to validate the dose distribution computed for a square beam in complex areas (head and neck, lungs, prostatic area). Finally, IMRT treatment simulations are validated. Results We compare the results obtained using our approach, the Eclipse TPS (AAA), and Monte Carlo simulations for a 10 cm x 10 cm photon beam on phantoms extracted from clinical data. The same procedure is applied to validate IMRT treatments. To compare the dose distributions, 3D gamma indices are computed, as well as profile extractions. For IMRT treatments, the dose distribution is computed in less than one minute on a traditional computer. Conclusions We have demonstrated the performance of our dose distribution engine for IMRT. Our goal is to provide a fast and accurate solution for TPS quality control. Therefore, we are currently working on the development of arctherapy treatment simulations.
ISSN:1120-1797
1724-191X
DOI:10.1016/j.ejmp.2016.11.032